Ikarian Capital, LLC Novavax Inc Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $49,413 - $102,544	-1,362 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $5,508 - $11,289	79 Added 6.16%	1,362 $100,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $240,563 - $366,094	-1,353 Reduced 51.33%	1,283 $266,000
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $209,403 - $470,552	2,636 New	2,636 $286,000
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $98,442 - $400,784	-25,049 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$3.69 - $5.22 $92,430 - $130,755	25,049 New	25,049 $100,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.